TORONTO, Feb. 21, 2018 -- Penfund, an independent provider of junior capital to middle market companies in the United States and Canada, announced today the completion of an investment in CBI Health Group (“CBI”), a portfolio company of OMERS Private Equity (“OPE”).
Penfund Capital Fund V (the “Fund”) provided a C$55.0 million lead order for a new C$70.0 million subordinated credit facility to support a dividend recapitalization of CBI. Penfund also acted as sole underwriter and agent of the subordinated credit facility. Jeremy Thompson, a partner at Penfund, stated, “We are delighted to be able to support OMERS again and are excited to partner with CBI as they continue to execute their growth strategy.”
About CBI Health Group
Headquartered in Toronto, Ontario, CBI is a leading national provider of home health and outpatient rehab services in Canada. From over 250 facilities, CBI provides services from a dedicated team of more than 12,000 that includes physiotherapists, occupational therapists, registered massage therapists, kinesiologists, chiropractors, speech-language pathologists, psychologists, physicians, nurses, caregivers, dieticians and behaviour therapists. CBI’s expanding transitional and residential community care network now numbers more than 100 homes nationwide.
Website: www.cbi.ca
About OMERS Private Equity
OMERS Private Equity invests globally in private equity assets on behalf of the OMERS pension plan. Investments are aimed at generating strong returns to help deliver secure and sustainable pensions to OMERS members. OMERS Private Equity has offices in Toronto, New York, and London. OMERS is one of Canada’s largest pension funds with net assets of C$85 billion.
Website: www.omersprivatemarkets.com
About Penfund
Penfund is a leading provider of junior capital to middle market companies throughout North America. The firm is owned by its management team and is currently investing its most recently established fund, Penfund Capital Fund V. Penfund manages funds sourced from pension funds, insurance companies, banks, family offices and high-net-worth individuals and has invested more than C$3 billion in over 225 companies since its establishment in 1979. Assets and capital under management exceed C$1.1 billion.
Website: www.penfund.com
For further information, please contact:
| Penfund Jeremy Thompson Partner (416) 645-3790 [email protected] | Penfund Adam Breslin Partner (416) 645-3796 [email protected] | Penfund Nicole Fich Partner (416) 645-3791 [email protected] |


Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Amazon Explores AI Content Marketplace With Media Publishers
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 



